POC Troponin/Cardiac

Anteo works with BBI - gold nanoparticles explores troponin

Partners with IMRA to develop Gold Nanoparticle Kit (To be released at AACC 2016 Next week)

Announce work in Quarterly report being done in Lateral Flow POC

"A good example of the quality of our work is illustrated in the testing we have undertaken in non-optimised lateral flow sample assays. Using Troponin (a marker for heart disorders, including myocardial infarction) as a model system under laboratory conditions, the limit of detection we have achieved is 5pg/ml. This result compares favourably with results delivered by IVD laboratory analysers. Similarly our 200nm kit, applied directly to Hepatitis B in serum, provided results as low as 1ng/ml - comparable with tests available on the market."

Announces partnership with ATOMO to develop Heart Attack POC test

Attending AACC alongside IMRA and Scienion

Announces new COO Tamara Mills -

"Director Cardiology Business"

"Leads the Diagnostic Cardiology business"

"Head of medical device development and commercialization."


Seems to be a bit of a theme but perhaps I am just seeing things